After high-temperature sealing, SWCNTs were covalently functionalized with the monoclonal antibody (mAb) Cetuximab (Erbitux®) targeting the epidermal growth factor receptor (EGFR), overexpressed on several cancer cells. This evidence concerns the gene EGFR and cancer.